Figures & data
Table 1. In vivo human phage therapy trials
Table 2. Phage-mediated biocontrol of bacterial growth in ethanol fermentation, foods, and beverages
Table 3. In vitro phage therapy against clinical isolates assays
Table 4. In vivo and ex vivo phage therapy experiments in animal models/tissues, fish, plants, poultry, piggery, and bees
Table 5. Phage application in biosanitization
Leszczyński P, et al. Successful eradication of methicillin-resistant Staphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker–case report. Folia Microbiol (Praha). 2006;51(3):236–238. . Marza JAS, et al. Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients. Burns. 2006;32(5):644–646. . Fadlallah A, Chelala E, Legeais J-MJTOOJ. Corneal infection therapy with topical bacteriophage administration. 2015;9:167. Markoishvili K, et al. A novel sustained‐release matrix based on biodegradable poly (ester amide) s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. 2002;41(7):453–458. Wright A, et al. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy. 2009;34(4):349–357. Sarker S, et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. 2016;4:124–137. Khawaldeh A, et al. Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection. J Med Microbiol. 2011;60(Pt 11):1697–1700. . Letkiewicz S, et al. Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis—case report. 2009;54(5):457. Verstappen KM, et al. The effectiveness of bacteriophages against methicillin-resistant Staphylococcus aureus ST398 nasal colonization in pigs. PLoS One. 2016;11(8):e0160242. Roach DR, et al. Bacteriophage-encoded lytic enzymes control growth of contaminating Lactobacillus found in fuel ethanol fermentations. 2013;6(1):20. McCallin S, et al. Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects. 2013;443(2):187–196. Khatibi PA, et al. Saccharomyces cerevisiae expressing bacteriophage endolysins reduce Lactobacillus contamination during fermentation. 2014;7(1):104. Obeso JM, et al. Use of logistic regression for prediction of the fate of Staphylococcus aureus in pasteurized milk in the presence of two lytic phages. Appl Environ Microbiol. 2010;76(18):6038–6046. . Liu M, et al. Bacteriophage application restores ethanol fermentation characteristics disrupted by Lactobacillusfermentum. 2015;8(1):132. Fish R, et al. Bacteriophage treatment of intransigent diabetic toe ulcers: a case series. 2016;25(Sup7):S27–S33. Carlton RM, Noordman WH, Biswas B, et al. Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul Toxicol Pharmacol. 2005;43(3):301–312. . Lee Y-D, Park J-H. Characterization and application of phages isolated from sewage for reduction of Escherichia coli O157:H7 in biofilm. Lebensmittel-Wissenschaft + [i.e. und] Tech. 2015;60(no. 1):571–577–2015. Tomat D, Mercanti D, Balagué C, et al. Phage biocontrol of enteropathogenic and Shiga toxin-producing Escherichia coli during milk fermentation. Lett Appl Microbiol. 2013;57(1):3–10. . Guenther S, Loessner MJ. Bacteriophage biocontrol of Listeria monocytogenes on soft ripened white mold and red-smear cheeses. J App Bacteri. 2011;1(2):94–100. Vonasek EL, et al. Incorporating phage therapy into WPI dip coatings for applications on fresh whole and cut fruit and vegetable surfaces. 2018;83(7):1871–1879. Leverentz B, et al. Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. 2003;69(8):4519–4526. Guenther S, et al. Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods. J App environ microbio. 2009;75(1):93–100. Deasy T, et al. Isolation of a virulent Lactobacillus brevis phage and its application in the control of beer spoilage. 2011;74(12):2157–2161. Augustine J, Bhat SG. Biocontrol of Salmonella Enteritidis in spiked chicken cuts by lytic bacteriophages ΦSP‐1 and ΦSP‐3. J basic microbio. 2015;55(4):500–503. Patel J, et al. Inactivation of Escherichia coli O157: H7 attached to spinach harvester blade using bacteriophage. 2011;8(4):541–546. Jun JW, et al. Eating oysters without risk of vibriosis: application of a bacteriophage against Vibrio parahaemolyticus in oysters. 2014;188:31–35. Bandara N, et al. Bacteriophages BCP1-1 and BCP8-2 require divalent cations for efficient control of Bacillus cereus in fermented foods. 2012;31(1):9–16. Lone A, et al. Development of prototypes of bioactive packaging materials based on immobilized bacteriophages for control of growth of bacterial pathogens in foods. 2016;217:49–58. Kim KP, Klumpp J, Loessner MJ. Enterobacter sakazakii bacteriophages can prevent bacterial growth in reconstituted infant formula. Int J Food Microbiol. 2007;115(2):195–203. Huang C, et al. Isolation, characterization, and application of a novel specific Salmonella bacteriophage in different food matrices. Food Res Int. 2018;111:631–641. Endersen L, Buttimer C, Nevin E, et al. Investigating the biocontrol and anti-biofilm potential of a three phage cocktail against Cronobacter sakazakii in different brands of infant formula. Int J Food Microbiol. 2017;253:1–11. Jun JW, et al. Bacteriophages reduce Yersinia enterocolitica contamination of food and kitchenware. 2018;271:33–47. Gouvêa DM, et al. Acetate cellulose film with bacteriophages for potential antimicrobial use in food packaging. 2015;63(1):85–91. Gouvêa DM, et al. Absorbent food pads containing bacteriophages for potential antimicrobial use in refrigerated food products. 2016;67:159–166. Pereira C, et al. Application of phage therapy during bivalve depuration improves Escherichia coli decontamination. 2017;61:102–112. Ryan EM, et al. Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. 2012;65(2):395–398. Dini C, De Urraza PJ. Isolation and selection of coliphages as potential biocontrol agents of enterohemorrhagic and Shiga toxin-producing E. coli (EHEC and STEC) in cattle. J Appl Microbiol. 2010;109(3):873–887. Kusmiatun A, Rusmana I, Budiarti S. Characterization of bacteriophage specific to bacillus pumilus from Ciapus River in Bogor, West Java, Indonesia. HAYATI J Biosci. 2015;22(1):27–33. Kvachadze L, et al. Evaluation of lytic activity of staphylococcal bacteriophage Sb‐1 against freshly isolated clinical pathogens. 2011;4(5):643–650. Pereira C, et al. Bacteriophages with potential to inactivate Salmonella Typhimurium: use of single phage suspensions and phage cocktails. 2016;220:179–192. Sillankorva S, Neubauer P, Azeredo JJBB. Pseudomonas fluorescens biofilms subjected to phage phiIBB-PF7A. 2008;8(1):79. Jung L-S, et al. Evaluation of lytic bacteriophages for control of multidrug-resistant Salmonella Typhimurium. 2017;16(1):1–9. Alves DR, et al. Development of a high-throughput ex-vivo burn wound model using porcine skin, and its application to evaluate new approaches to control wound infection. J Frontiers cellular infec microbio. 2018;8:196. Ghosh A, et al. Combined application of essential oil compounds and bacteriophage to inhibit growth of Staphylococcus aureus in vitro. 2016;72(4):426–435. Alves DR, et al. A novel bacteriophage cocktail reduces and disperses P seudomonas aeruginosa biofilms under static and flow conditions. J Microbial biotech. 2016;9(1):61–74. Alves D, et al. Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation. J App Environ Microbio. 2014;80(21):6694–6703. Lungren MP, et al. Bacteriophage K for reduction of Staphylococcus aureus biofilm on central venous catheter material. 2013;3(4):e26825. Carson L, Gorman S, Gilmore B. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. 2010;59(3):447–455. Nouraldin AAM, et al. Bacteriophage-antibiotic synergism to control planktonic and biofilm producing clinical isolates of Pseudomonas aeruginosa. 2016;52(2):99–105. Vipra AA, et al. Antistaphylococcal activity of bacteriophage derived chimeric protein P128. 2012;12(1):41. Chhibber S, Nag D, Bansal SJBM. Inhibiting biofilm formation by Klebsiella pneumoniae B5055 using an iron antagonizing molecule and a bacteriophage. 2013;13(1):1–8. Abdulamir AS, et al. The potential of bacteriophage cocktail in eliminating Methicillin-resistant Staphylococcus aureus biofilms in terms of different extracellular matrices expressed by PIA, ciaA-D and FnBPA genes. 2015;14(1):49. Didamony GE, Askora A, Shehata AA. Isolation and characterization of T7-Like Lytic Bacteriophages Infecting multidrug resistant pseudomonas aeruginosa isolated from Egypt. Curr Microbiol. 2015;70(6):786–791. Chen L-K, et al. Potential of bacteriophage ΦAB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii. 2013;13(1):1–10. Niculae C-M, et al. The 12th Edition of the Scientific Days of the National Institute for Infectious Diseases “Prof. Dr. Matei Bals” and the 12th National Infectious Diseases Conference. 99. Neguț AC, Săndulescu O, Streinu-Cercel A, et al. Influence of bacteriophages on sessile Gram-positive and Gramnegative bacteria. . in BMC Infectious diseases. 2016. BioMed Central. Woo J, Ahn JJAOM. Assessment of synergistic combination potential of probiotic and bacteriophage against antibiotic-resistant Staphylococcus aureus exposed to simulated intestinal conditions. 2014;196(10):719–727. Morris J, et al. Evaluation of bacteriophage anti-biofilm activity for potential control of orthopedic implant-related infections caused by Staphylococcus aureus. 2019;20(1):16–24. Fu W, et al. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. 2010;54(1):397–404. Olszak T, et al. In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients. 2015;99(14):6021–6033. Guang-Han O, et al. Experimental phage therapy for Burkholderia pseudomallei infection. 2016;11(7):e0158213. Chhibber S, Gupta P, Kaur SJBM. Bacteriophage as effective decolonising agent for elimination of MRSA from anterior nares of BALB/c mice. 2014;14(1):212. Abdulamir AS, et al. Novel approach of using a cocktail of designed bacteriophages against gut pathogenic E. colifor bacterial load biocontrol. 2014;13(1):39. Kishor C, et al. Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model. Indian J Med Res. 2016;143(1):87–94. . Furusawa T, et al. Phage therapy is effective in a mouse model of bacterial equine keratitis. 2016;82(17):5332–5339. Jeon J, et al. In vivo application of bacteriophage as a potential therapeutic agent to control OXA-66-like carbapenemase-producing Acinetobacter baumannii strains belonging to sequence type 357. 2016;82(14):4200–4208. Wang Y, et al. Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia. 2016;11(5):631–641. Yen M, Cairns LS, Camilli AJNC. A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models. 2017;8(1):1–7. Augustine J, Gopalakrishnan MV, Bhat SG. Application of ΦSP-1 and ΦSP-3 as a therapeutic strategy against Salmonella Enteritidis infection using Caenorhabditis elegans as model organism. J FEMS Microbio Letters. 2014;356(1):113–117. Vieira A, et al. Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments. 2012;31(11):3241–3249. Yin S, Huang G, Zhang Y, et al. Phage Abp1 rescues human cells and mice from infection by pan-drug resistant Acinetobacter Baumannii. Cell Physiol Biochem. 2017;44(6):2337–2345. . Kumari S, Harjai K, Chhibber Sjtjoiidc. Topical treatment of Klebsiella pneumoniae B5055 induced burn wound infection in mice using natural products. 2010;4(6):367–377. Wei C, et al. Developing a bacteriophage cocktail for biocontrol of potato bacterial wilt. Virol Sin. 2017;32(6):476–484. . Kocharunchitt C, Ross T, McNeil DL. Use of bacteriophages as biocontrol agents to control Salmonella associated with seed sprouts. Int J Food Microbiol. 2009;128(3):453–459. Elhalag K, et al. Potential use of soilborne lytic Podoviridae phage as a biocontrol agent against Ralstonia solanacearum. J Basic Microbiol. 2018;58(8):658–669. . Soleimani-Delfan A, et al. Isolation of Dickeya dadantii strains from potato disease and biocontrol by their bacteriophages. 2015;46(3):791–797. Tan D, et al. Vibriophages differentially influence biofilm formation by Vibrio anguillarum strains. Appl Environ Microbiol. 2015;81(13):4489–4497. Khairnar K, et al. Novel bacteriophage therapy for controlling metallo-beta-lactamase producing Pseudomonas aeruginosainfection in Catfish. BMC Vet Res. 2013;9(1):264. . Christiansen RH, et al. Effect of bacteriophages on the growth of flavobacterium psychrophilum and development of phage-resistant strains. Microb Ecol. 2016;71(4):845–859. Silva YJ, et al. Phage therapy as an approach to prevent Vibrio anguillarum infections in fish larvae production. 2014;9(12):e114197. Stalin N, Srinivasan P. Characterization of Vibrio parahaemolyticus and its specific phage from shrimp pond in Palk Strait, South East coast of India. Biologicals. 2016;44(6):526–533. Kittler S, et al. Effect of bacteriophage application on Campylobacter jejuni loads in commercial broiler flocks. 2013;79(23):7525–7533. Lau GL, Sieo CC, Tan WS, et al. Characteristics of a phage effective for colibacillosis control in poultry. J Sci Food Agric. 2012;92(13):2657–2663. . Belgini DRB, et al. Culturable bacterial diversity from a feed water of a reverse osmosis system, evaluation of biofilm formation and biocontrol using phages. World J Microbiol Biotechnol. 2014;30(10):2689–2700. . Rodríguez-Rubio L, et al. Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. Crit Rev Microbiol. 2013;39(4):427–434. . Beims H, et al. Paenibacillus larvae-directed bacteriophage HB10c2 and its application in American foulbrood-affected honey bee larvae. 2015;81(16):5411–5419. Maal KB, et al. Isolation and identification of two novel Escherichia Coli bacteriophages and their application in wastewater treatment and coliform’s phage therapy. 2015;8:3. J Jundishapur j microbio. Bull JJ, Levin BR, DeRouin T, et al. Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol. 2002;2(1):35. Ho YH, et al. Application of bacteriophage-containing aerosol against nosocomial transmission of carbapenem-resistant acinetobacter baumannii in an intensive care unit. PLoS One. 2016;11(12):e0168380. . Akimkin V, Shestopalov N, Shumilov V, et al. ICPIC, meeting abstracts from international conference on prevention & infection control (ICPIC 2017), biological disinfection with bacteriophages. Antimicrob Resist Infect Control. 2017;6(3):52. O’flaherty S, et al. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. 2005;71(4):1836–1842. Brown TL, et al. The formulation of bacteriophage in a semi solid preparation for control of propionibacterium acnes growth. PLoS One. 2016;11(3):e0151184. . Beckner M, Ivey ML, Phister TG. Microbial contamination of fuel ethanol fermentations. 2011;53(4):387–394.